Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 08-2015 | 10-2013 | 10-2012 | 10-2011 | 10-2010 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | 343 | 457 | 371 | 122 |
| Accounts receivable | 66 | 212 | -60 | -156 | -33 |
| Accounts payable and accrued liabilities | -60 | 69 | -55 | 185 | N/A |
| Other Working Capital | -46 | 281 | -82 | -276 | -97 |
| Other Operating Activity | -1,460 | -584 | -124 | -319 | -323 |
| Operating Cash Flow | $-1,501 | $321 | $136 | $-195 | $-330 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 722 | -71 | -274 | -698 | N/A |
| Purchase Sale Intangibles | -37 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -285 |
| Investing Cash Flow | $685 | $-71 | $-274 | $-698 | $-285 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 288 | 330 | 348 |
| Debt Repayment | -99 | -365 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 37 | N/A |
| Other Financing Activity | 472 | 0 | 0 | 494 | 0 |
| Financing Cash Flow | $373 | $-365 | $288 | $861 | $348 |
| Beginning Cash Position | 703 | 181 | 31 | 63 | 330 |
| End Cash Position | 260 | 66 | 181 | 31 | 63 |
| Net Cash Flow | $-443 | $-115 | $149 | $-32 | $-267 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,501 | 321 | 136 | -195 | -330 |
| Capital Expenditure | -37 | -92 | -274 | -698 | -285 |
| Free Cash Flow | -1,538 | 229 | -138 | -893 | -616 |